Lv21
130 积分 2023-11-03 加入
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
2小时前
已完结
Nivolumab for Resected Stage III or IV Melanoma at 9 Years
8天前
已完结
High-speed spectral domain polarization- sensitive optical coherence tomography using a single camera and an optical switch at 1.3 µm
10天前
已完结
Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study
1个月前
已完结
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
1个月前
已完结
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study
1个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1个月前
已完结
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
1个月前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
1个月前
已完结
Overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
1个月前
已完结
皖公网安备34019202002308
